Supportive care is a high importance area in cancer care and management. Prevention of radiotherapy and chemotherapy induced anemia, management of mucosal injury, treatment of dyspnea, management of cancer pain, venous thromboembolism, bone metastases, cardiovascular toxicity and others hold a critical significance and specific guidelines have been established for delivering best cancer treatment outcomes.
This report titled “Cancer Supportive Care Market - Growth, Future Prospects and Competitive Analysis, 2021 - 2029” is to offer industry investors, company executives, and industry participants with in depth insights to enable them make informed strategic decisions related to the opportunities in the cancer supportive care drugs market. The major target audience of this study include industry investors, cancer drugs manufacturers, distributors, and institutional scholars.
This study classifies the global cancer supportive care market into type therapeutics, cancer types, sales channels and geographical distribution. Based on therapeutic types, the overall market is studied for Oral Mucositis and Dry Mouth, Chemotherapy Induced Nausea and Vomiting, Cancer Pain, Chemotherapy Induced Anemia, Chemotherapy Induced Neutropenia and Bone Metastases. Lung Cancer, Liver Cancer, Breast Cancer, Leukemia, Prostate Cancer, Ovarian Cancer, Bladder Cancer and cancers are the major oncology areas for which the cancer supportive care market is studied. The sales channels considered for distribution of cancer supportive care drugs are hospital pharmacies, retail pharmacies and compounding pharmacies. Market size and forecast for each mentioned segment are provided in this report for the period 2019-2029 (US$ Mn), along with respective CAGR (value %) for the period 2021-2029.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global cancer supportive care market. Tools such as market positioning of key players, and attractive investment proposition provide the readers with insights on the competitive scenario of the global cancer supportive care market. This report concludes with company profiles section that highlights major information about the key players engaged in development, manufacture and sales of cancer supportive care drugs.
This product will be delivered within 2 business days.
This report titled “Cancer Supportive Care Market - Growth, Future Prospects and Competitive Analysis, 2021 - 2029” is to offer industry investors, company executives, and industry participants with in depth insights to enable them make informed strategic decisions related to the opportunities in the cancer supportive care drugs market. The major target audience of this study include industry investors, cancer drugs manufacturers, distributors, and institutional scholars.
This study classifies the global cancer supportive care market into type therapeutics, cancer types, sales channels and geographical distribution. Based on therapeutic types, the overall market is studied for Oral Mucositis and Dry Mouth, Chemotherapy Induced Nausea and Vomiting, Cancer Pain, Chemotherapy Induced Anemia, Chemotherapy Induced Neutropenia and Bone Metastases. Lung Cancer, Liver Cancer, Breast Cancer, Leukemia, Prostate Cancer, Ovarian Cancer, Bladder Cancer and cancers are the major oncology areas for which the cancer supportive care market is studied. The sales channels considered for distribution of cancer supportive care drugs are hospital pharmacies, retail pharmacies and compounding pharmacies. Market size and forecast for each mentioned segment are provided in this report for the period 2019-2029 (US$ Mn), along with respective CAGR (value %) for the period 2021-2029.
Geographically, the global cancer supportive care market is studied for the following regional markets:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- Japan
- China
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of LATAM
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global cancer supportive care market. Tools such as market positioning of key players, and attractive investment proposition provide the readers with insights on the competitive scenario of the global cancer supportive care market. This report concludes with company profiles section that highlights major information about the key players engaged in development, manufacture and sales of cancer supportive care drugs.
Based on the type cancers where supportive care is significantly in demand, the global cancer supportive care market is segmented as follows:
- Lung Cancer
- Liver Cancer
- Breast Cancer
- Leukemia
- Prostate Cancer
- Ovarian Cancer
- Bladder Cancer
- Others
Based on the type of sales channel, the global cancer supportive care market is segmented as follows:
- Hospital Pharmacies
- Retail Pharmacies
- Compounding pharmacies
Based on the therapeutic areas, the global cancer supportive care market is segmented as follows:
- Oral Mucositis and Dry Mouth
- Chemotherapy Induced Nausea and Vomiting
- Cancer Pain
- Chemotherapy Induced Anemia
- Chemotherapy Induced Neutropenia
- Bone Metastases
For the purpose of this study, the global cancer supportive care market is categorized as follows:
- North America (U.S., Canada)
- Europe (U.K., Germany, Rest of Europe)
- Asia Pacific (Japan, China, Australia, Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Rest of Latin America)
- Middle East and Africa (Saudi Arabia, South Africa, Rest of MEA)
This product will be delivered within 2 business days.
Table of Contents
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Global Cancer Supportive Care Market Overview
Chapter 4 Global Cancer Supportive Care Market (US$ Mn), By Therapeutic Area, 2019-2029
Chapter 5 Global Cancer Supportive Care Market (US$ Mn), By Cancer Type, 2019-2029
Chapter 6 Global Cancer Supportive Care Market (US$ Mn), By Sales Channel, 2019-2029
Chapter 7 Global Cancer Supportive Care Market (US$ Mn), By Geography, 2019-2029
Chapter 8 Company Profiles
Companies Mentioned
- Amgen Inc.
- Novartis AG
- Johnson & Johnson
- Pfizer
- Teva Pharmaceutical Industries Ltd.
- Hoffmann-La Roche Ltd.
- Baxter International Inc.
- Fagron Group BV
- Helsinn Group
- Acacia Pharma Ltd